Sign in
CAMRF Stock Price, Chart, Stats & News
Camurus AB
Save
Camurus AB (CAMRF) does not currently pay a dividend.
3.67B
Market cap
51.96x
Current P/E
26.32x
Forward P/E
CAMRF chart
About
Health care
Sector
Biotechnology
Industry
Camurus AB operates as a research based pharmaceutical company. The firm engages in the research, development and commercialization of specialty medicines. It provides its products for the treatment of severe and chronic conditions, which includes opioid dependence, pain, cancer and endocrine disorders.
Similar securities
Based on sector and market capitalization
Report issue